Silene Biotech
stem cell banking, patient-specific stem cells
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
stem cell banking, patient-specific stem cells
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Silene Biotech stem cell banking, patient-specific stem cells
Silene Biotech is described as a Seattle biotechnology company focused on stem cell banking and services. Its work centered on consumer stem cell banking, patient-specific stem-cell processes, and personalized technologies using patient stem cells. NanoSurface Biomedical acquired Silene's IP, cGMP laboratory facilities, and research, development, and operations teams in 2019.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Silene Biotech — Far from goals · Bottom quartile. Derived deterministically from 2 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (2 programs at undisclosed).…
Source: Deterministic